CPC A61K 36/9068 (2013.01) [A61K 35/618 (2013.01); A61K 35/62 (2013.01); A61K 36/062 (2013.01); A61K 36/233 (2013.01); A61K 36/284 (2013.01); A61K 36/344 (2013.01); A61K 36/484 (2013.01); A61K 36/54 (2013.01); A61K 36/65 (2013.01); A61K 36/69 (2013.01); A61K 36/752 (2013.01); A61K 36/8888 (2013.01); A61K 36/899 (2013.01); A61P 3/06 (2018.01); A61P 9/10 (2018.01)] | 9 Claims |
1. An oral formulation for preventing or treating increased blood lipids, increased triglyceride, increased cholesterol, hyperlipidemia and atherosclerosis wherein the oral formulation is prepared by decocting and/or extracting the following raw materials in part by weight: 20-30 parts of thorowax root, 10-20 parts of immature orange fruit, 5-15 parts of raw rhubarb, 5-10 parts of baical skullcap root, 5-15 parts of white peony root, 5-10 parts of dried ginger, 7-15 parts of leech, 5-15 parts of liquorice root, 5-15 parts of tangshen, 5-15 parts of largehead atractylodes rhizome and 10-20 parts of pinellia tuber, and wherein the oral formulation is in oral dosage form selected from the group consisting of a tablet, a sugar-coated tablet, a film-coated tablet, an enteric-coated tablet, a capsule, a hard capsule, a soft capsule, a lozenge, a granule, a pill, a suspension, a pellet, and an ointment.
|